Is tonghua dongbao Pharmaceutical Co., Ltd. a listed company?

be

Tonghua dongbao is a developer of diabetes drugs. The products are mainly aimed at diabetic patients, including conventional insulin (Gansulin R), moderate insulin (Gansulin N) and 30/70 mixed recombinant human insulin injection (Gansulin 30R). At the same time, it also provides users with blood glucose meter, GM700 blood glucose monitoring and management system, blood collection pen and test paper.

More peer analysis, the company knows and understands.